Immunomodulatory serum components in head and neck cancer
- 1 April 1993
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 29 (2) , 103-106
- https://doi.org/10.1016/0964-1955(93)90030-i
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Immunosuppressive substance in the sera of head and neck cancer patientsCancer, 1988
- Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexesJournal of Oral Pathology & Medicine, 1987
- Tumor growth promoting activity of an immunosuppressive substance and its modulation by protein-bound polysaccharide PSKImmunology Letters, 1987
- Purification and characterization of immunosuppressive (IS) substance obtained from ascitic fluids of patients with gastrointestinal cancerClinical Biochemistry, 1987
- Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant womenCancer, 1986
- Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.Journal of Clinical Investigation, 1977
- The C1q Binding Test for Soluble Immune Complexes: Clinical Correlations Obtained in Patients With Cancer 2JNCI Journal of the National Cancer Institute, 1977
- FACTORS INTERFERING WITH IMMUNOLOGICAL REJECTION OF TUMOURSBritish Medical Bulletin, 1976
- Association of Anergy with an Immunosuppressive Peptide Fraction in the Serum of Patients with CancerNew England Journal of Medicine, 1974
- Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor AntigensPublished by Elsevier ,1974